These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Barr AM; Lehmann-Masten V; Paulus M; Gainetdinov RR; Caron MG; Geyer MA Neuropsychopharmacology; 2004 Feb; 29(2):221-8. PubMed ID: 14603268 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Morice E; Denis C; Giros B; Nosten-Bertrand M Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485 [TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice. Yarkov AV; Hanger D; Reploge M; Joyce JN Pharmacol Biochem Behav; 2003 Dec; 76(3-4):551-62. PubMed ID: 14643855 [TBL] [Abstract][Full Text] [Related]
8. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Tillerson JL; Caudle WM; Parent JM; Gong C; Schallert T; Miller GW Behav Brain Res; 2006 Sep; 172(1):97-105. PubMed ID: 16765459 [TBL] [Abstract][Full Text] [Related]
9. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455 [TBL] [Abstract][Full Text] [Related]
10. Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior. Lucas LR; Celen Z; Tamashiro KL; Blanchard RJ; Blanchard DC; Markham C; Sakai RR; McEwen BS Neuroscience; 2004; 124(2):449-57. PubMed ID: 14980394 [TBL] [Abstract][Full Text] [Related]
12. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. Mateo Y; Budygin EA; John CE; Banks ML; Jones SR J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348 [TBL] [Abstract][Full Text] [Related]
13. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Powell SB; Lehmann-Masten VD; Paulus MP; Gainetdinov RR; Caron MG; Geyer MA Psychopharmacology (Berl); 2004 May; 173(3-4):310-7. PubMed ID: 14747902 [TBL] [Abstract][Full Text] [Related]
14. Increased rewarding properties of morphine in dopamine-transporter knockout mice. Spielewoy C; Gonon F; Roubert C; Fauchey V; Jaber M; Caron MG; Roques BP; Hamon M; Betancur C; Maldonado R; Giros B Eur J Neurosci; 2000 May; 12(5):1827-37. PubMed ID: 10792459 [TBL] [Abstract][Full Text] [Related]
15. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422 [TBL] [Abstract][Full Text] [Related]
16. Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Hall FS; Sora I; Uhl GR Neuropsychopharmacology; 2003 Apr; 28(4):620-8. PubMed ID: 12655306 [TBL] [Abstract][Full Text] [Related]
17. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739 [TBL] [Abstract][Full Text] [Related]
18. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Spielewoy C; Roubert C; Hamon M; Nosten-Bertrand M; Betancur C; Giros B Behav Pharmacol; 2000 Jun; 11(3-4):279-90. PubMed ID: 11103882 [TBL] [Abstract][Full Text] [Related]
19. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. Mead AN; Rocha BA; Donovan DM; Katz JL Eur J Neurosci; 2002 Aug; 16(3):514-20. PubMed ID: 12193195 [TBL] [Abstract][Full Text] [Related]
20. Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction. Hironaka N; Ikeda K; Sora I; Uhl GR; Niki H Ann N Y Acad Sci; 2004 Oct; 1025():140-5. PubMed ID: 15542711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]